RemeGen Co., Ltd. (HKG:9995)
Hong Kong
· Delayed Price · Currency is HKD 77.25
+9.10 (13.35%)
Aug 14, 2025, 3:45 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 40.17 billion as of August 13, 2025. Its market cap has increased by 193.86% in one year.
Market Cap
40.17B
Enterprise Value
42.32B
Revenue
2.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
77.25
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 40.17B, an increase of 20.30%. That is a compound annual growth rate of 3.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 40.14B | 186.62% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | 46.53B | 39.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 250.26B |
| Hansoh Pharmaceutical Group Company | 210.48B |
| JD Health International | 168.01B |
| Innovent Biologics | 154.06B |
| Akeso | 144.33B |
| Sino Biopharmaceutical | 132.88B |
| WuXi Biologics | 120.98B |
| CSPC Pharmaceutical Group | 118.45B |